---
figid: PMC12113536__metabolites-15-00304-g004
figtitle: Nucleotide biosynthetic pathway as a potential metabolic vulnerability in
  RTs
organisms:
- NA
organisms_ner:
- NA
pmcid: PMC12113536
filename: metabolites-15-00304-g004.jpg
figlink: /pmc/articles/PMC12113536/figure/F4/
number: F4
caption: The nucleotide biosynthetic pathway as a potential metabolic vulnerability
  in RTs. ‘AMP’ denotes adenosine monophosphate, ‘GMP’ guanine monophosphate, ‘UMP’
  uridine monophosphate, and ‘CTP’ cytidine triphosphate. Figure created using BioRender.com
papertitle: 'SMARCB1 Deficiency as a Driver of the Hallmarks of Cancer in Rhabdoid
  Tumours: Novel Insights into Dysregulated Energy Metabolism, Emerging Targets, and
  Ongoing Clinical Trials'
reftext: Abdul L. Shakerdi, et al. Metabolites. 2025 May;15(5).
year: '2025'
doi: 10.3390/metabo15050304
journal_title: Metabolites
journal_nlm_ta: Metabolites
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: rhabdoid tumours | SMARCB1 deficiency | hallmarks of cancer | energy metabolism
  | targeted therapy
automl_pathway: 0.9441804
figid_alias: PMC12113536__F4
figtype: Figure
redirect_from: /figures/PMC12113536__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12113536__metabolites-15-00304-g004.html
  '@type': Dataset
  description: The nucleotide biosynthetic pathway as a potential metabolic vulnerability
    in RTs. ‘AMP’ denotes adenosine monophosphate, ‘GMP’ guanine monophosphate, ‘UMP’
    uridine monophosphate, and ‘CTP’ cytidine triphosphate. Figure created using BioRender.com
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Dihydrofolate
  - Tetrahydrofolate
  - Inosine monophosphate
  - Orotate
  - Methotrexate
  - UMP
  - AMP
  - GMP
  - CTP
---
